Semaglutide versus tirzepatide for people with type 2 diabetes: cost of glycemic control in Austria, the Netherlands, Lithuania, and the United Arab Emirates-Reference-Cited by-同舟云学术

Semaglutide versus tirzepatide for people with type 2 diabetes: cost of glycemic control in Austria, the Netherlands, Lithuania, and the United Arab Emirates

Published:2023-07-10 Issue:8 Volume:39 Page:1055-1060
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Reitzel Signe Baattrup¹^ORCID,Bøgelund Mette¹^ORCID,Basse Amaury²^ORCID,Barszczewska Olga²^ORCID,Ren Hongye³^ORCID

Affiliation:

1. Department of Economics, EY Denmark, Frederiksberg, Denmark

2. Middle East & Africa, Novo Nordisk Region South East Europe, Zurich, Switzerland

3. Middle East & Africa, Novo Nordisk Region North West Europe, Copenhagen S, Denmark

Funder

Novo Nordisk North West Europe

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2231275

Reference23 articles.

1. IDF Diabetes Atlas | Tenth Edition. [Internet]; [cited 2023 Jan 25]. Available from https://diabetesatlas.org/.

2. IDF. Type 2 diabetes [Internet]; [cited 2023 Jan 25]. Available from: https://www.idf.org/aboutdiabetes/type-2-diabetes.html.

3. The Clinical and Public Health Challenges of Diabetes Prevention: A Search for Sustainable Solutions

4. World Health Organization. Diabetes [Internet]. 2022; [cited 2022 Nov 2]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.

5. Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta‐Analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia;Journal of Medical Economics;2024-03-11